Predatory drug pricing needs targeted legislation, enforcement, US DOJ, FTC told

By Khushita Vasant, Alex Wilts and Clayton Vickers ( July 25, 2025, 01:33 GMT | Insight) -- Federal Trade Commission and US Department of Justice antitrust enforcers heard from pharmaceutical industry stakeholders today on the need for enforcement and legislation targeting high drug prices and reform in drug supply chain practices, while seeking a balanced view on the role of pharmacy benefit managers who are often vilified for reaping high profits.Federal Trade Commission and US Department of Justice antitrust enforcers heard from pharmaceutical industry stakeholders today on the need for enforcement and legislation targeting high drug prices and reform in drug supply chain practices, while seeking a balanced view on the role of pharmacy benefit managers who are often vilified for reaping high profits....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.

Know what others in the room don’t, with features including:

Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Predatory drug pricing needs targeted legislation, enforcement, US DOJ, FTC told

Prepare for tomorrow’s regulatory change, today

Related Sections